XPhyto Therapeutics (CSE: XPHY- OTCQB: XPHYF) CEO Hugh Rogers joined Steve Darling from Proactive with news the company has set out a very aggressive work plan for 2021. Rogers talks about some of the milestones they are planning this year including Clinical Studies, Development, and Manufacturing.
XPhyto Therapeutics looking to hit milestones in 2021 as they move to development and manufacturing